Dapagliflozin, an SGLT2 Inhibitor, Enhances Antihypertensive and Glucose Metabolism Effects of Renin‒Angiotensin System Inhibitor in Japanese Patients with Type 2 Diabetes Mellitus and Hypertension
Arata Iwasaki and et al., Therapeutic Research, 37, 581-592 (2016), DOI:http://dx.doi.org/